Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors have?
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors has 469 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors published?
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors has 2014 year in the ScholarIQ index.
What is the open-access status of Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors?
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors has closed oa status in the ScholarIQ index.
What is the DOI of Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors?
The DOI for Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors is on the source record.
What is the PMID of Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors?
The PMID for Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors is on the source record.
What is the OpenAlex record for Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors?
The OpenAlex for Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors is on the source record.